Online inquiry

IVTScrip™ mRNA-Human ACTG2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK10660MR)

This product GTTS-WK10660MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ACTG2 protein. This product can be used in Mitotic fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001199893.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 72
UniProt ID P63267
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ACTG2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK10660MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK25348MR IVTScrip™ mRNA-Human ARL6IP4, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA ARL6IP4
GTTS-WK17911MR IVTScrip™ mRNA-Human ANKRD26P1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD26P1
GTTS-WK9900MR IVTScrip™ mRNA-Human Aggrecan, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA Aggrecan
GTTS-WK5927MR IVTScrip™ mRNA-Human CD24, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA CD24
GTTS-WK21241MR IVTScrip™ mRNA-Human ANKUB1, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ANKUB1
GTTS-WK2419MR IVTScrip™ mRNA-Human RUNX2, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA RUNX2
GTTS-WK17031MR IVTScrip™ mRNA-Human ANKRD54, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ANKRD54
GTTS-WK25666MR IVTScrip™ mRNA-Human ARPC1B, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARPC1B
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →